Effect of curcumin on down-expression of thrombospondin-4 induced by oxidized low-density lipoprotein in mouse macrophages

Bio-Medical Materials and Engineering

Volumn 24, Issue 1, 2014, Pages 181-189

  Zhou, Zhong Yun ^a   Chen, Yi Qing ^b   Wang, Fei Yan ^a   Tian, Nan ^a   Fan, Chun Lei ^a  

^a ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^b GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

angiogenesis; atherosclerosis; Curcumin; oxidized low density lipoprotein; thrombospondin 4

Indexed keywords

ANGIOGENESIS; ATHEROSCLEROSIS; CURCUMIN; OXIDIZED LOW-DENSITY LIPOPROTEINS; THROMBOSPONDIN-4;

BIOMEDICAL ENGINEERING; BIOTECHNOLOGY; CELL CULTURE; CYTOTOXICITY; LIPOPROTEINS; MACROPHAGES; MAMMALS; OXIDATION; POLYMERASE CHAIN REACTION;

GENE EXPRESSION;

CURCUMIN; OXIDIZED LOW DENSITY LIPOPROTEIN; THROMBOSPONDIN; THROMBOSPONDIN 4; UNCLASSIFIED DRUG;

CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANGIOGENESIS; ATHEROSCLEROSIS; CURCUMIN; OXIDIZED LOW-DENSITY LIPOPROTEIN; THROMBOSPONDIN-4;

ANIMALS; ATHEROSCLEROSIS; CELL LINE; CELL SURVIVAL; CURCUMIN; DOWN-REGULATION; ENZYME INHIBITORS; LIPOPROTEINS, LDL; MACROPHAGES; MEDICINE, CHINESE TRADITIONAL; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; THROMBOSPONDINS;

EID: 84891137408     PISSN: 09592989     EISSN: None     Source Type: Journal    
DOI: 10.3233/BME-130798     Document Type: Conference Paper

References (32)

1. G.K. Hansson, A. Hermansson, The immune system in atherosclerosis, Nat Immunol 12 (2011), 204-212.
2. G. Newton, S. Weremowicz, C.C. Morton et al., The thrombospondin-4 gene, Mamm Genome 10 (1999), 1010-1016.
3. J.C. Adams and J. Lawler, The thrombospondins, Int J Biochem Cell Biol 36 (2004), 961-968.
4. C.N. Tymchuk, J. Hartiala, P.I. Patel, M. Mehrabian and H. Allayee, Nonconventional genetic risk factors for cardiovascular disease, Curr Atheroscler Rep 8 (2006), 184-192.
5. A. Forslow, Z. Liu and K.G. Sundqvist, Receptor communication within the lymphocyte plasma membrane: A role for the thrombospondin family of matricellular proteins, Cell Mol Life Sci 64 (2007), 66-76.
6. E.J. Topol, J. McCarthy, S. Gabriel et al., Single nucleotide polymorphisms in multiple novel thrombospondin genes may be as-sociated with familial premature myocardial infarction, Circulation 104 (2001), 2641-2644.
7. S.C Gupta, S. Patchva, W. Koh and B.B Aggarwal, Discovery of curcumin, a component of the golden spice, and its miraculous biological activities, Clin Exp Pharmacol Physiol 39 (2012), 283-299.
8. M.J. Park, E.H. Kim, I.C. Park et al., Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitor, p2IWAF1/CIPI, p27KIP1 and p53, Int J Oncol 21 (2002), 379-383.
9. R.A. Sharma, W.P. Steward and A.J. Gescher, Pharmacokinetics and pharmacodynamics of curcumin, Adv Exp Med Biol 595 (2007), 453-470.
10. L. Qin, X.P. Qin, Z. Wang, B.Y. Zhu and D.F. Liao, Effect of pravastatin on cholesteryl esters in foam cells and the relation with caveolin-1, Acta Physiol Sin 58 (2006), 47-52.
11. D. Li and J.L. Mehta, Oxidized LDL, a critical factor in atherogenesis, Cardiovasc Res 68 (2005), 353-354.
12. Y.I. Miller, S.H. Choi, L. Fang and S. Tsimikas, Lipoprotein modification and macrophage uptake: Role of pathologic cholesterol transport in atherogenesis, Subcell Biochem 51 (2010), 229-251.
13. R. Stocker and J.F.Jr. Keaney, Role of oxidative modifications in atherosclerosis, Physiol Rev 84 (2004), 1381-1478.
14. K.J. Moore and I. Tabas, Macrophages in the pathogenesis of atherosclerosis, Cell 145 (2011), 341-355.
15. A. Dandapat, C. Hu, L. Sun and J.L. Mehta, Small concentrations of oxLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway, Arterioscler Thromb Vasc Biol 27 (2007), 2435-2442.
16. S. Yu, S.L. Wong, C.W. Lau, Y. Huang and C.M. Yu, Oxidized LDL at low concentration promotes in-vitro angiogenesis and activates nitric oxide synthase through PI3K/Akt/eNOS pathway in human coronary artery endothelial cells, Biochem Biophys Res Commun 407 (2011), 44-48.
17. V.N. Bochkov, M. Philippova, O. Oskolkova et al., Oxidized phospholipids stimulate angiogenesis via autocrine mechanisms, implicating a novel role for lipid oxidation in the evolution of atherosclerotic lesions, Circ Res 99 (2006), 900-908.
18. J.C. Sluimer and M.J. Daemen, Novel concepts in atherogenesis: Angiogenesis and hypoxia in atherosclerosis, J Pathol 218 (2007), 7-29.
19. P. Bornstein, Thrombospondins as matricellular modulators of cell function, J Clin Invest 107 (2001), 929-934.
20. J.C. Adams, Thrombospondins: Multifunctional regulators of cell interactions, Annu Rev Cell Dev Biol 17 (2001), 25-51.
21. Y. Yamada, H. Izawa, S. Ichihara et al., Prediction of the risk of myocardial infarction from polymorphisms in candidate genes, N Engl J Med 347 (2002), 1916-1923.
22. J. Wessel, E.J. Topol, M. Ji, J. Meyer and J.J. McCarthy, Replication of the association between the thrombospondin-4 A387P polymorphism and myocardial infarction, Am Heart J 147 (2004), 905-909.
23. E. Pluskota, O.I. Stenina, I. Krukovets, D. Szpak, E.J. Topol and E.F. Plow, Mechanism and effect of thrombospondin-4 polymorphisms on neutrophil function, Blood 106 (2005), 3970-3978.
24. K. Gupta, P. Gupta, R. Wild, S. Ramakrishnan and R.P. Hebbel, Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: Effect on human microvascular endothelial cell proliferation and angiogenesis, Angiogenesis 3 (1999), 147-158.
25. P. Bornstein, Thrombospondins function as regulators of angiogenesis, J Cell Commun Signal 3 (2009), 189-200.
26. B. Margosio, M. Rusnati, K. Bonezzi et al., Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain, Int J Biochem Cell Biol 40 (2008), 700-709.
27. T. Myers, S. Chengedza, S. Lightfoot et al., Flexible heteroarotinoid (Flex-Het) SHetA2 inhibits angiogenesis in vitro and in vivo, Invest New Drugs 27 (2009), 304-318.
28. M. Naito, X. Wu, H. Nomura et al., The protective effects of tetrahydrocurcumin on oxidative stress in cholesterol-fed rabbits, J Atheroscler Thromb 9 (2002), 243-250.
29. R. Olszanecki, J. Jawie-, M. Gajda et al., Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice, J Physiol Pharmacol 56 (2005), 627-635.
30. X. Yang, D.P. Thomas, X. Zhang et al., Curcumin Inhibits Platelet-Derived Growth Factor-Stimulated Vascular Smooth Muscle Cell Function and Injury-Induced Neointima Formation, Arterioscler Thromb Vasc Biol 26 (2006), 85-90.
31. A.E. Gururaj, M. Belakavadi, D.A. Venkatesh, D. Marme and B.P. Salimath, Molecular mechanisms of anti-angiogenic effect of curcumin, Biochem Biophys Res Commun 297 (2002), 934-942.
32. A.B. Kunnumakkara, S. Guha, S. Krishnan et al., Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor- B regulated gene products, Cancer Res 67 (2007), 3853-3861.